Staar Surgical Co (NASDAQ:STAA) traded at $16.63 at close of the session on Tuesday, February 18 and made an upward move of 8.34% on its previous day’s price.
Staar Surgical Co has a market cap of $819.46 million and is expected to release its quarterly earnings report in March.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 40.33M, with a low of 39.7M and a high of 41.55M. The median projection represents growth adding up to -47.87% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 261.02M, or -16.85% down from figures reported last year.
On the other hand, looking at the outlook for the STAA stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 13 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Staar Surgical Co (STAA) stock as a Hold, while 11 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -24.47% off its SMA20 and -28.73% from its 50-day simple moving average. The RSI (14) is pointing at 28.14 while the volatility over the past week is 11.06% and jumps to 5.96% over the past one month. The beta value is 0.62, while the average true range (ATR) is currently pointing at 1.59. The average price target for the stock over the next 12 months is $48, with the estimates having a low of $45.03 and a high of $85. These price ends are -170.78% and -411.12% off the current price level respectively, although investors could be excited at the prospect of a -188.63% if the STAA share price touches on the median price of $48.
